Abstract:Purpose: To determine whether ACE(2) I/D and BDKRB2(3) + 9/ - 9 polymorphism causatively affect diabetic nephropathy progressionResults: STZ-induced metabolic disorder, as well as inflammatory responses, was significantly aggravated in ACE II-B2R(4) + 9 bp, ACE DD-B2R + 9 bp, or ACE DD-B2R - 9 bp diabetic mice but not ACE II-B2R - 9 bp, indicating the genetic susceptibility of ACE DD or B2R + 9 bp to diabetic nephropathy. Furthermore, ACE II-B2R + 9 bp, ACE DD-B2R + 9 bp, or ACE DD-B2R - 9 bp rather than ACE II-B2R - 9 bp, worsened renal performance and enhanced pathological alterations induced by STZ. Markedly elevated monocyte chemoattractant protein-1(MCP-1), podocin, osteopontin (OPN), transforming growth factor-beta 1 (TGF-beta 1), and reduced nephrin, podocin were also detected both in diabetic mice and podocytes under hyperglycemic conditions in response to ACE II-B2R + 9 bp, ACE DD-B2R + 9 bp, or ACE DD-B2R - 9 bp, versus ACE II-B2R - 9 bp. In addition, high glucose induced mitochondrial oxidative stress and cell apoptosis were observably increased in response to ACE II-B2R + 9 bp, ACE DD-B2R + 9 bp, or ACE DD-B2R - 9 bp but not ACE II-B2R - 9 bp.Conclusions: We provide first evidence indicating the causation between ACE DD or B2R + 9 bp genotype and the increased risk for diabetic nephropathy, broadening our horizon about the role of genetic modulators in this disease.

Relationship of Angiotensin I-converting Enzyme (ACE) and Bradykinin B2 Receptor (BDKRB2) Polymorphism with Diabetic Nephropathy